SCHEMBL798084

SCHEMBL798084

Fc1ccc(CCCc2nc3c(N4CCNCC4)nc([AsH2])nc3s2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 2/20 0.35
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
HTR6 P50406 2/20 0.35
SOS1 Q07889 1/20 0.34
PTGS2 P35354 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2C9 P11712 2/20 0.33
HSD17B10 Q99714 2/20 0.33
CSNK1A1 P48729 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
HRH4 Q9H3N8 2/20 0.33
HRH3 Q9Y5N1 1/20 0.33
ADORA2A P29274 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL798130 0.98 HTR3A (0.35) HTR3AESR1ESR2HTR6SOS1
SCHEMBL798140 0.88 HTR3A (0.37) HTR3AHTR6SOS1ALDH1A1CYP1A2
SCHEMBL655227 0.88 HRH4 (0.43) HTR3AESR1ESR2HTR6HRH4
SCHEMBL656370 0.85 HRH4 (0.43) HTR3AESR1ESR2HTR6HRH4
SCHEMBL654836 0.81 HRH4 (0.45) HTR3AHTR6HRH4HRH3KCNH2
SCHEMBL655975 0.78 ADORA2A (0.49) HTR3AHTR6ALDH1A1CYP1A2CYP3A4
SCHEMBL656382 0.75 HRH4 (0.46) HTR3AHTR6HRH4HRH3KCNH2
SCHEMBL1720675 0.73 ADORA2A (0.44) HTR6HRH4HRH3ADORA2AMEN1
SCHEMBL1720807 0.71 HRH4 (0.46) HTR6CYP3A4HRH4HRH3KCNH2
SCHEMBL656256 0.70 HRH4 (0.44) HTR3ACYP3A4HRH4HRH3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616077-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2013-07-24 EP disclosed
WO-2012035423-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2012-03-22 WO disclosed